2018 Virginia Fetal Cardiology Symposium

2018 Virginia Fetal Cardiology Symposium is organized by University of Virginia and will be held during May 18 - 19, 2018 at Hilton Richmond Hotel & Spa/Short Pump, Richmond, Virginia, United States of America.

The target audience for this medical event is Physicians, Physician Assistants, Sonographers, Cardiovascular Technicians, Nurse Practitioners, Registered Nurses, and Genetic Counselors. This CME Conference has been approved for a maximum of 9.25 AMA PRA Category 1 Credits.

Conference Description :
This symposium focuses on improving congenital heart disease detection rates in obstetrics and maternal-fetal medicine offices through improved fetal cardiac screening processes. Sessions include fetal echocardiography basics in addition to evaluation of perinatal conditions known to affect the fetal heart including twin-to-twin transfusion syndrome, maternal diabetes, teratogens and connective tissue disorders.

Special consideration will also be given to topics on various advanced fetal interventions, comprehensive genetic screening and issues surrounding family counseling and delivery. The afternoon portion of the main conference will have breakout sessions allowing attendees to choose to join a series of topics on Fetal Echocardiography and/or a series of topics on Maternal-Fetal Medicine.

Conference Objectives are :
• State the purpose of the basic fetal shunts and cardiac connections and how they transition at the time of birth
• Differentiate between evidence-based reasons to perform fetal echocardiography and conditions that do not warrant comprehensive fetal heart evaluation
• List the standard fetal echocardiographic views and how the comprehensive exam is performed
• Plan how early genetic and cardiac screening can increase rates of prenatal diagnosis and how these screens can be appropriately applied to standard first-trimester evaluation
• Generalize the approach and evidence for recommending chromosomal testing when a fetal cardiac disease is diagnosed
• Generalize the approach and evidence for recommending focused genetic testing when a known family history of an inherited cardiac condition exists
• Classify the levels of severity for Twin-to-Twin transfusion syndrome and how those levels affect the decision for fetal intervention
• Examine how known twin-to-twin transfusion syndrome affects both twin’s cardiovascular system including implications for perinatal outcomes
• Differentiate between all of the causes of fetal cardiomegaly and criteria that are used to accurately classify it
• Identify when the patient with fetal hypoplastic left heart syndrome becomes higher risk and what echocardiographic findings suggest a change in delivery planning and prognosis
• Define the basic right heart obstructive lesions including pulmonary atresia and pulmonary stenosis and how they are diagnosed on fetal echocardiography
• Illustrate how malformation of the placenta and umbilical arteries are associated with a physiologic effect on the heart as well as congenital heart lesions
• State the basic echocardiographic findings of left heart obstructive disease including aortic stenosis, coarctation and hypoplastic left heart syndrome
• Compare the effects of gestational diabetes and pre-pregnancy maternal diabetes on the developing heart and the function of the heart at the time of delivery
• Summarize the major conotruncal defects including Tetralogy of Fallot, Transposition of the great arteries and, and truncus arteriosus and explore how they are diagnosed in utero
• List the common maternal teratogens that have known associations with congenital heart disease and how to minimize their effect and exposure
• Apply basic m-mode and fetal Doppler assessment to identify and risk stratify fetal arrhythmia
• Examine the different genetic syndromes that are associated with congenital heart disease and how their diagnoses are suggested by ultrasound
• Discriminate between the positives and negatives of engaging in social media while counseling patients with known fetal cardiac disease
• List the major hemodynamic issues surrounding women with congenital heart disease who become pregnant and how those issues can risk stratify them during their whole course
• Critique the use of hyperoxygenation in assessing pulmonary blood flow in patients at risk for diminished states at the time of birth
• Evaluate how intervention on the developing fetal heart affects outcomes postnatally and where the evidence exists in supporting the continued development of these techniques
• Summarize the many different ways that parents seek out information about congenital heart programs and discriminate between reputable reporting systems and data that comes internally from individual programs
• Examine the issues surrounding labor and delivery management for pregnancies complicated by fetal cardiac disease
• Examine the issues surrounding the immediate post-natal period for infants with known or suspected fetal cardiac disease
• Illustrate how various neurodevelopmental tools can be utilized to describe outcomes for patients who were diagnosed prenatally with cardiac disease in contrast to those with postnatal diagnoses